Epidemiology and Immune Pathogenesis of Viral Sepsis

被引:202
作者
Lin, Gu-Lung [1 ,2 ]
McGinley, Joseph P. [1 ,2 ]
Drysdale, Simon B. [1 ,2 ,3 ]
Pollard, Andrew J. [1 ,2 ]
机构
[1] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, England
[2] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England
[3] St Georges Univ Hosp NHS Fdn Trust, Dept Paediat, London, England
来源
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
关键词
viral sepsis; epidemiology; immune pathogenesis; herpes simplex virus; human enterovirus; human parechovirus; influenza virus; dengue virus; HERPES-SIMPLEX-VIRUS; TOLL-LIKE-RECEPTOR; T-CELL DIFFERENTIATION; PRIMARY IMMUNODEFICIENCY DISEASES; RESPIRATORY-DISTRESS-SYNDROME; HUMAN PARECHOVIRUS TYPE-3; DECAY-ACCELERATING FACTOR; ENTEROVIRUS; 71; INFECTION; PEDIATRIC SEVERE SEPSIS; TUMOR-NECROSIS-FACTOR;
D O I
10.3389/fimmu.2018.02147
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis can be caused by a broad range of pathogens; however, bacterial infections represent the majority of sepsis cases. Up to 42% of sepsis presentations are culture negative, suggesting a non-bacterial cause. Despite this, diagnosis of viral sepsis remains very rare. Almost any virus can cause sepsis in vulnerable patients (e.g., neonates, infants, and other immunosuppressed groups). The prevalence of viral sepsis is not known, nor is there enough information to make an accurate estimate. The initial standard of care for all cases of sepsis, even those that are subsequently proven to be culture negative, is the immediate use of broad-spectrum antibiotics. In the absence of definite diagnostic criteria for viral sepsis, or at least to exclude bacterial sepsis, this inevitably leads to unnecessary antimicrobial use, with associated consequences for antimicrobial resistance, effects on the host microbiome and excess healthcare costs. It is important to understand non-bacterial causes of sepsis so that inappropriate treatment can be minimised, and appropriate treatments can be developed to improve outcomes. In this review, we summarise what is known about viral sepsis, its most common causes, and how the immune responses to severe viral infections can contribute to sepsis. We also discuss strategies to improve our understanding of viral sepsis, and ways we can integrate this new information into effective treatment.
引用
收藏
页数:21
相关论文
共 282 条
  • [1] The Toll-Like Receptor 3-Mediated Antiviral Response Is Important for Protection against Poliovirus Infection in Poliovirus Receptor Transgenic Mice
    Abe, Yuko
    Fujii, Ken
    Nagata, Noriyo
    Takeuchi, Osamu
    Akira, Shizuo
    Oshiumi, Hiroyuki
    Matsumoto, Misako
    Seya, Tsukasa
    Koike, Satoshi
    [J]. JOURNAL OF VIROLOGY, 2012, 86 (01) : 185 - 194
  • [2] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL
    ABRAHAM, E
    WUNDERINK, R
    SILVERMAN, H
    PERL, TM
    NASRAWAY, S
    LEVY, H
    BONE, R
    WENZEL, RP
    BALK, R
    ALLRED, R
    PENNINGTON, JE
    WHERRY, JC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12): : 934 - 941
  • [3] Why immunomodulatory therapies have not worked in sepsis
    Abraham, E
    [J]. INTENSIVE CARE MEDICINE, 1999, 25 (06) : 556 - 566
  • [4] A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis
    Abzug, Mark J.
    Michaels, Marian G.
    Wald, Ellen
    Jacobs, Richard F.
    Romero, Jose R.
    Sanchez, Pablo J.
    Wilson, Gregory
    Krogstad, Paul
    Storch, Gregory A.
    Lawrence, Robert
    Shelton, Mark
    Palmer, April
    Robinson, Joan
    Dennehy, Penelope
    Sood, Sunil K.
    Cloud, Gretchen
    Jester, Penelope
    Acosta, Edward P.
    Whitley, Richard
    The, David Kimberlin
    [J]. JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2016, 5 (01) : 53 - 62
  • [5] Abzug MJ, 2015, NELSON TXB PEDIAT, V1, P1561
  • [6] Maternal morbidity and mortality from severe sepsis: a national cohort study
    Acosta, Colleen D.
    Harrison, David A.
    Rowan, Kathy
    Lucas, D. Nuala
    Kurinczuk, Jennifer J.
    Knight, Marian
    [J]. BMJ OPEN, 2016, 6 (08):
  • [7] The Continuum of Maternal Sepsis Severity: Incidence and Risk Factors in a Population-Based Cohort Study
    Acosta, Colleen D.
    Knight, Marian
    Lee, Henry C.
    Kurinczuk, Jennifer J.
    Gould, Jeffrey B.
    Lyndon, Audrey
    [J]. PLOS ONE, 2013, 8 (07):
  • [8] Sepsis and maternal mortality
    Acosta, Colleen D.
    Knight, Marian
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2013, 25 (02) : 109 - 116
  • [9] Pathogen recognition and innate immunity
    Akira, S
    Uematsu, S
    Takeuchi, O
    [J]. CELL, 2006, 124 (04) : 783 - 801
  • [10] Incidence and risk factors of sepsismortality in labor, delivery and after birth: Population-based study in the USA
    Al-Ostad, Ghassan
    Kezouh, Abbas
    Spence, Andrea R.
    Abenhaim, Haim A.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2015, 41 (08) : 1201 - 1206